UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Journal of Crohn's & colitis, 2010-02, Vol.4 (1), p.28-62

2010

Volltextzugriff (PDF)

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

Journal of Crohn's and colitis, 2008-03, Vol.2 (1), p.1-23

2008

Volltextzugriff (PDF)

Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype

Digestive and liver disease, 2007-08, Vol.39 (8), p.733-739

2007

Volltextzugriff (PDF)

1098 LIVER REGENERATION WITH CONCOMITANT BONE MARROW-DERIVED MESENCHYMAL STROMAL CELL THERAPY TO TREAT LIVER FIBROSIS

Journal of hepatology, 2011-03, Vol.54, p.S434-S435

2011

Volltextzugriff (PDF)

580 COMBINED DONOR-RECIPIENT MANNOSE-BINDING LECTIN AND FICOLIN-2 GENE POLYMORPHISMS PREDISPOSE TO HUMAN CYTOMEGALOVIRUS INFECTION AFTER ORTHOTOPIC LIVER TRANSPLANTATION

Journal of hepatology, 2011-03, Vol.54, p.S236-S236

2011

Volltextzugriff (PDF)

573 MATRIX METALLOPROTEINASE-2 GENOTYPE IS AN INDEPENDENT RISK FACTOR FOR NON-ANASTOMOTIC BILIARY STRICTURES AFTER ORTHOTOPIC LIVER TRANSPLANTATION

Journal of hepatology, 2011-03, Vol.54, p.S233-S233

2011

Volltextzugriff (PDF)

496 LECTIN COMPLEMENT PATHWAY GENES OF DONOR AND RECIPIENT DETERMINE THE RISK OF CLINICALLY SIGNIFICANT INFECTIONS AFTER ORTHOTOPIC LIVER TRANSPLANTATION

Journal of hepatology, 2010, Vol.52, p.S200-S200

2010

Volltextzugriff (PDF)

CO29 AUTOPHAGY INDUCES IMMUNE TOLERANCE BY REGULATING INTERACTIONS BETWEEN DENDRITIC CELLS-EPITHELIAL CELL IN THE GUT

Digestive and liver disease, 2011, Vol.43, p.S408-S408

2011

Volltextzugriff (PDF)

Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's disease

Digestive and liver disease, 2007-02, Vol.39 (2), p.182-186

2007

Volltextzugriff (PDF)

Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease

Journal of Crohn's and colitis, 2013-04, Vol.7 (3), p.213-221

2013

Volltextzugriff (PDF)

P748 High stress and significant decrease in productivity in caregivers of IBD patients

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S464-S465

2017

Volltextzugriff (PDF)

Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study

Inflammatory bowel diseases, 2011-09, Vol.17 (9), p.1837-1845

2011

Volltextzugriff (PDF)

Rage signalling promotes intestinal tumourigenesis

Oncogene, 2013-02, Vol.32 (9), p.1202-1206

2013

Volltextzugriff (PDF)

P077 Effects of IFN-γ priming on the functional characteristics of human bone marrow and adipose derived mesenchymal stem cells expanded in alternative xeno-free conditions

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S94-S94

2014

Volltextzugriff (PDF)

More right‐sided IBD‐associated colorectal cancer in patients with primary sclerosing cholangitis

Inflammatory bowel diseases, 2009-09, Vol.15 (9), p.1331-1336

2009

Volltextzugriff (PDF)

P354 The effect of value based health care delivery for inflammatory bowel diseases on outcomes of patients

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S257-S257

2017

Volltextzugriff (PDF)

New cytokine therapeutics for inflammatory bowel disease

Cytokine (Philadelphia, Pa.), 2004-11, Vol.28 (4), p.167-173

2004

Volltextzugriff (PDF)

P063 Identification of novel non-transcriptionally acting glucocorticoid receptor ligands that suppress T cell activation but lack adipogenic activity

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S89-S89

2014

Volltextzugriff (PDF)

E23 Framework for integration of research and clinical care in the 21st century: Looking forward in a new decade

Journal of Crohn's and colitis supplements, 2010-04, Vol.4 (1), p.18

2010

Volltextzugriff (PDF)

E23 Framework for integration of research and clinical care in the 21 st century: Looking forward in a new decade

Journal of Crohn's and colitis supplements, 2010, Vol.4 (1), p.18-18

2010

Volltextzugriff (PDF)

P327 The value of social media in inflammatory bowel diseases

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S201-S201

2014

Volltextzugriff (PDF)

DOP026 Work related problems and impaired productivity in patients with inflammatory bowel diseases (IBD)

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S27-S27

2014

Volltextzugriff (PDF)

P086 Donor dependent efficacy of human mesenchymal stromal cell treatment in experimental colitis

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S43-S44

2013

Volltextzugriff (PDF)

Mortality in hereditary antithrombin-III deficiency—1830 to 1989

The Lancet (British edition), 1991-02, Vol.337 (8736), p.260-262

1991

Volltextzugriff (PDF)

DOP099 Five-year safety results from the ENCORE registry: Malignancies in patients with Crohn's disease treated with infliximab, standard therapy, or switched from standard therapy to infliximab

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S63-S63

2014

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype

1098 LIVER REGENERATION WITH CONCOMITANT BONE MARROW-DERIVED MESENCHYMAL STROMAL CELL THERAPY TO TREAT LIVER FIBROSIS

580 COMBINED DONOR-RECIPIENT MANNOSE-BINDING LECTIN AND FICOLIN-2 GENE POLYMORPHISMS PREDISPOSE TO HUMAN CYTOMEGALOVIRUS INFECTION AFTER ORTHOTOPIC LIVER TRANSPLANTATION

573 MATRIX METALLOPROTEINASE-2 GENOTYPE IS AN INDEPENDENT RISK FACTOR FOR NON-ANASTOMOTIC BILIARY STRICTURES AFTER ORTHOTOPIC LIVER TRANSPLANTATION

496 LECTIN COMPLEMENT PATHWAY GENES OF DONOR AND RECIPIENT DETERMINE THE RISK OF CLINICALLY SIGNIFICANT INFECTIONS AFTER ORTHOTOPIC LIVER TRANSPLANTATION

CO29 AUTOPHAGY INDUCES IMMUNE TOLERANCE BY REGULATING INTERACTIONS BETWEEN DENDRITIC CELLS-EPITHELIAL CELL IN THE GUT

Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's disease

Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease

P748 High stress and significant decrease in productivity in caregivers of IBD patients

Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study

Rage signalling promotes intestinal tumourigenesis

P077 Effects of IFN-γ priming on the functional characteristics of human bone marrow and adipose derived mesenchymal stem cells expanded in alternative xeno-free conditions

More right‐sided IBD‐associated colorectal cancer in patients with primary sclerosing cholangitis

P354 The effect of value based health care delivery for inflammatory bowel diseases on outcomes of patients

New cytokine therapeutics for inflammatory bowel disease

P063 Identification of novel non-transcriptionally acting glucocorticoid receptor ligands that suppress T cell activation but lack adipogenic activity

E23 Framework for integration of research and clinical care in the 21st century: Looking forward in a new decade

E23 Framework for integration of research and clinical care in the 21 st century: Looking forward in a new decade

P327 The value of social media in inflammatory bowel diseases

DOP026 Work related problems and impaired productivity in patients with inflammatory bowel diseases (IBD)

P086 Donor dependent efficacy of human mesenchymal stromal cell treatment in experimental colitis

Mortality in hereditary antithrombin-III deficiency—1830 to 1989

DOP099 Five-year safety results from the ENCORE registry: Malignancies in patients with Crohn's disease treated with infliximab, standard therapy, or switched from standard therapy to infliximab

Suchergebnisse filtern